跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACTEMRA SC tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, ACTPen Autoinjector - TGA Drug Approval Details
Approvals
/
TGA
/
ACTEMRA SC tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, ACTPen Autoinjector
Approved
STANDARD
ACTEMRA SC tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, ACTPen Autoinjector
Roche Products Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a80647a7b83e548b
Company
Roche Products Pty Ltd
Type
Standard
Approval Details
Approval Id
a80647a7b83e548b
Product Name
ACTEMRA SC tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, ACTPen Autoinjector
Artg Id
370314
Artg Name
ACTEMRA SC tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen ACTPen Autoinjector
Sponsor
Roche Products Pty Ltd
Company Detail Path
/organization/roche-products-pty-ltd
Artg Date
2021-11-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4a8d49dca07e07d17a73213e41dcb7b9.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/6c090b9948031f5beb9f7c953b22cdd5.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a80647a7b83e548b
Type
Standard
Back to TGA Approvals